We used data from the Health and Retirement Survey in the US, and the English Longitudinal Study for Aging from
England, including non-Hispanic White respondents aged 50–64 years (US market-based v NHS) and .65 years (USMedicare
v NHS) with diagnosed hypertension. We compared blood pressure control to clinical guideline (140/90 mmHg)
and audit (150/90 mmHg) targets; mean systolic and diastolic blood pressure and antihypertensive prescribing, and
disparities in each by educational attainment, income and wealth, using regression models.